Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT05295394
What this trial is testing

Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study

Who this might be right for
HIV-1 Infection
Pedro Cahn
Large-scale testing (Phase 3)Study completedNCT01440569
What this trial is testing

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 314
Not applicableUnknownNCT03183154
What this trial is testing

Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected

Who this might be right for
HIV-1-infection
Hospital General Universitario Gregorio Marañon 1,831
Large-scale testing (Phase 3)Study completedNCT00358917
What this trial is testing

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Who this might be right for
Human Immunodeficiency Virus Infections
Abbott 599
Large-scale testing (Phase 3)Study completedNCT02131233
What this trial is testing

Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 802
Early research (Phase 1)Study completedNCT04927585
What this trial is testing

Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

Who this might be right for
HIV Infections
Worcester HIV Vaccine 42
Early research (Phase 1)Study completedNCT02591420
What this trial is testing

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT03360682
What this trial is testing

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

Who this might be right for
HIV-1-infectionSolid Organ Transplant
Fundacion Clinic per a la Recerca Biomédica 19
Post-approval studies (Phase 4)Not Yet RecruitingNCT06580873
What this trial is testing

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

Who this might be right for
HIV-1-infectionOpioid Use Disorder
Saskatchewan Health Authority - Regina Area 40
Large-scale testing (Phase 3)Study completedNCT04399551
What this trial is testing

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

Who this might be right for
HIV Infections
ViiV Healthcare 437
Large-scale testing (Phase 3)Active Not RecruitingNCT06630286
What this trial is testing

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 609
Large-scale testing (Phase 3)Active Not RecruitingNCT06532656
What this trial is testing

Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 75
Post-approval studies (Phase 4)WithdrawnNCT03813979
What this trial is testing

Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls.

Who this might be right for
HIV-1-infectionHepatic Impairment
Radboud University Medical Center
Early research (Phase 1)Study completedNCT05406583
What this trial is testing

The Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT00476853
What this trial is testing

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 42
Not applicableNot Yet RecruitingNCT06637813
What this trial is testing

Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine

Who this might be right for
HIV -1 Infection
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,220
Early research (Phase 1)UnknownNCT05001373
What this trial is testing

Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)

Who this might be right for
Hiv
International AIDS Vaccine Initiative 56
Not applicableUnknownNCT05332470
What this trial is testing

A Real-world Study of Lamivudine and Dotiravir Sodium Tablets in the Treatment-naïve HIV-1 Infected Patients

Who this might be right for
HIV-1-infection
Peking Union Medical College Hospital 200
Early research (Phase 1)WithdrawnNCT03505060
What this trial is testing

Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT05598580
What this trial is testing

Immunomodulators on HIV-1 Reservoir

Who this might be right for
HIV Infections
First Affiliated Hospital of Zhejiang University 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation